245 related articles for article (PubMed ID: 32153402)
1. New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of
Dallons M; Schepkens C; Dupuis A; Tagliatti V; Colet JM
Front Pharmacol; 2020; 11():79. PubMed ID: 32153402
[TBL] [Abstract][Full Text] [Related]
2. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
[TBL] [Abstract][Full Text] [Related]
3. The Lack of Synergy between Carvedilol and the Preventive Effect of Dexrazoxane in the Model of Chronic Anthracycline-Induced Cardiomyopathy.
Szponar J; Ciechanski E; Ostrowska-Lesko M; Gorska A; Tchorz M; Dabrowska A; Dudka J; Murias M; Kowalczyk M; Korga-Plewko A; Mandziuk S
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373350
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
[TBL] [Abstract][Full Text] [Related]
5. Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity.
Lue Y; Gao C; Swerdloff R; Hoang J; Avetisyan R; Jia Y; Rao M; Ren S; Atienza V; Yu J; Zhang Y; Chen M; Song Y; Wang Y; Wang C
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H634-H643. PubMed ID: 29775411
[TBL] [Abstract][Full Text] [Related]
6. In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of doxorubicin (DOX) and dexrazoxane (DEX) interactions: Safety assessment and optimization.
Mody H; Vaidya TR; Ait-Oudhia S
Sci Rep; 2023 Feb; 13(1):3100. PubMed ID: 36813809
[TBL] [Abstract][Full Text] [Related]
7. The Prophylactic Effect of Pinocembrin Against Doxorubicin-Induced Cardiotoxicity in an
Sangweni NF; Moremane M; Riedel S; van Vuuren D; Huisamen B; Mabasa L; Barry R; Johnson R
Front Pharmacol; 2020; 11():1172. PubMed ID: 32903793
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine alleviates doxorubicin cardiotoxicity by inhibiting mitochondrial reactive oxygen species generation.
Yu JL; Jin Y; Cao XY; Gu HH
Hum Cell; 2020 Jan; 33(1):47-56. PubMed ID: 31643023
[TBL] [Abstract][Full Text] [Related]
9. Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p.
Yu X; Ruan Y; Shen T; Qiu Q; Yan M; Sun S; Dou L; Huang X; Wang Q; Zhang X; Man Y; Tang W; Jin Z; Li J
Biomed Res Int; 2020; 2020():5107193. PubMed ID: 32190669
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells.
Rharass T; Gbankoto A; Canal C; Kurşunluoğlu G; Bijoux A; Panáková D; Ribou AC
Mol Cell Biochem; 2016 Feb; 413(1-2):199-215. PubMed ID: 26833193
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
[TBL] [Abstract][Full Text] [Related]
13. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of secretory APE1/Ref-1 on doxorubicin-induced cardiotoxicity via suppression of ROS and p53 pathway.
An SY; Jin SA; Seo HJ; Lee YR; Kim S; Jeon BH; Jeong JO
ESC Heart Fail; 2024 Apr; 11(2):1182-1193. PubMed ID: 38286792
[TBL] [Abstract][Full Text] [Related]
16. Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusion in vitro.
Chahine N; Nader M; Duca L; Martiny L; Chahine R
Drug Chem Toxicol; 2016; 39(1):87-96. PubMed ID: 25885550
[TBL] [Abstract][Full Text] [Related]
17.
Mody H; Vaidya TR; Lezeau J; Taha K; Ait-Oudhia S
Front Pharmacol; 2023; 14():1239141. PubMed ID: 37927589
[TBL] [Abstract][Full Text] [Related]
18. p66Shc signaling is involved in stress responses elicited by anthracycline treatment of rat cardiomyoblasts.
Sampaio SF; Branco AF; Wojtala A; Vega-Naredo I; Wieckowski MR; Oliveira PJ
Arch Toxicol; 2016 Jul; 90(7):1669-84. PubMed ID: 26318906
[TBL] [Abstract][Full Text] [Related]
19. A novel agent attenuates cardiotoxicity and improves antitumor activity of doxorubicin in breast cancer cells.
Zhang Y; Deng H; Zhou H; Lu Y; Shan L; Lee SM; Cui G
J Cell Biochem; 2019 Apr; 120(4):5913-5922. PubMed ID: 30304553
[TBL] [Abstract][Full Text] [Related]
20. Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury.
Zhen J; Yu H; Ji H; Cai L; Leng J; Keller BB
Life Sci; 2019 Dec; 239():117070. PubMed ID: 31751580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
